» Articles » PMID: 12438370

Association Between the Tumor Necrosis Factor Locus and the Clinical Outcome of Leishmania Chagasi Infection

Abstract

A periurban outbreak of visceral leishmaniasis (VL) caused by the protozoan Leishmania chagasi is ongoing outside Natal, northeast Brazil. Manifestations range from asymptomatic infection to disseminated visceral disease. Literature reports suggest that both genetic and environmental factors influence the outcome of infection. Due to the association of the tumor necrosis factor (TNF) locus with other infectious diseases, we examined whether polymorphic alleles at this locus are associated with the outcome of L. chagasi infection. Neighborhoods with ongoing transmission were identified through patients admitted to local hospitals. Altogether, 1,024 individuals from 183 families were classified with the following disease phenotypes: (i) symptomatic VL, (ii) asymptomatic infection (positive delayed-type hypersensitivity [DTH+]), or (iii) no evidence of infection (DTH-). Genotypes were determined at a microsatellite marker (MSM) upstream of the TNFB gene encoding TNF-beta and at a restriction fragment length polymorphism (RFLP) at position -307 in the promoter of the TNFA gene encoding TNF-alpha. Analyses showed that the distribution of TNFA RFLP alleles (TNF1 and TNF2) and the TNF MSM alleles (TNFa1 to TNFa15) differed between individuals with VL and those with DTH+ phenotypes. TNF1 was transmitted more frequently than expected from heterozygous parents to DTH+ offspring (P = 0.0006), and haplotypes containing TNF2 were associated with symptomatic VL (P = 0.0265, transmission disequilibrium test). Resting serum TNF-alpha levels were higher in TNF1/2 heterozygotes than in TNF1/1 homozygotes (P < 0.05). These data led us to hypothesize that an individual's genotype at the TNF locus may be associated with whether he or she develops asymptomatic or symptomatic disease after L. chagasi infection. The results preliminarily suggest that this may be the case, and follow-up with larger populations is needed for verification.

Citing Articles

Human visceral leishmaniasis and polymorphisms in interleukin-coding genes: a systematic review.

Vieira A, de Menezes M, Farias P, da Silva E, Bezerra G, Barbosa W J Venom Anim Toxins Incl Trop Dis. 2024; 30:e20240018.

PMID: 39435399 PMC: 11493340. DOI: 10.1590/1678-9199-JVATITD-2024-0018.


Multi-omic Analyses of Plasma Cytokines, Lipidomics, and Transcriptomics Distinguish Treatment Outcomes in Cutaneous Leishmaniasis.

Malta-Santos H, Fukutani K, Sorgi C, Queiroz A, Nardini V, Silva J iScience. 2020; 23(12):101840.

PMID: 33313489 PMC: 7721649. DOI: 10.1016/j.isci.2020.101840.


Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Dayakar A, Chandrasekaran S, Kuchipudi S, Kalangi S Front Immunol. 2019; 10:670.

PMID: 31024534 PMC: 6459942. DOI: 10.3389/fimmu.2019.00670.


Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients.

Singh N, Kumar R, Engwerda C, Sacks D, Nylen S, Sundar S Cytokine. 2016; 85:184-90.

PMID: 27372917 PMC: 4947431. DOI: 10.1016/j.cyto.2016.06.013.


Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection.

Ramos P, Carvalho K, Santoro Rosa D, Rodrigues A, Lima L, Campos M Biomed Res Int. 2016; 2016:6937980.

PMID: 27051668 PMC: 4802012. DOI: 10.1155/2016/6937980.


References
1.
Kremsner P, Grundmann H, Neifer S, Sliwa K, Sahlmuller G, Hegenscheid B . Pentoxifylline prevents murine cerebral malaria. J Infect Dis. 1991; 164(3):605-8. DOI: 10.1093/infdis/164.3.605. View

2.
Sham P, Curtis D . Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995; 59(1):97-105. DOI: 10.1111/j.1469-1809.1995.tb01608.x. View

3.
Roy S, Frodsham A, Saha B, Hazra S, Mascie-Taylor C, Hill A . Association of vitamin D receptor genotype with leprosy type. J Infect Dis. 1998; 179(1):187-91. DOI: 10.1086/314536. View

4.
Zanelli E, Jones G, Pascual M, Eerligh P, van der Slik A, Zwinderman A . The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Hum Immunol. 2001; 62(1):75-84. DOI: 10.1016/s0198-8859(00)00227-5. View

5.
McGuire W, Hill A, Allsopp C, Greenwood B, Kwiatkowski D . Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994; 371(6497):508-10. DOI: 10.1038/371508a0. View